Tailoring Exercise Prescription for Effective Diabetes Glucose Management
Claudia Lewis1, Ebne Rafi1, Brandi Dobbs1
1Department of Endocrinology, University Hospitals Diabetes and Metabolic Care Center, Cleveland, OH 44106, USA.
The Journal of Clinical Endocrinology and Metabolism
|January 21, 2025
Summary
Regular physical activity and exercise improve glycemic control and cardiovascular health in people with type 1 diabetes mellitus (T1DM) and type 2 diabetes (T2DM). Further research is needed to optimize exercise prescriptions for maximum health benefits in real-world settings.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Exercise Physiology
Background:
- Physical activity and exercise are key components of diabetes management for both type 1 diabetes mellitus (T1DM) and type 2 diabetes (T2DM).
- Current evidence supports exercise for improving glycemic control, cardiovascular risk, weight management, and overall well-being.
- The optimal exercise prescription for individuals with diabetes remains an area of ongoing debate.
Purpose of the Study:
- To review the existing literature on the effects of exercise on insulin sensitivity and glycemic control in individuals with T1DM and T2DM.
- To identify gaps in knowledge regarding optimal exercise regimens and influencing factors for diabetes management.
Main Methods:
- A systematic search of PubMed and Google Scholar databases was conducted.
- Studies focusing on exercise, insulin sensitivity, and glycemic control in T1DM and T2DM populations were included.
Main Results:
- In T1DM, exercise enhances cardiovascular fitness, muscle strength, and glucose levels, though optimal combinations of aerobic and resistance training require further study.
- Factors influencing hypoglycemia during exercise in T1DM include insulin therapy, meal timing, and neuroendocrine regulation.
- In T2DM, physical activity is recommended irrespective of weight loss, with emerging focus on exercise timing, medication interactions, and sedentary behavior breaks for improved glucose management.
Conclusions:
- Exercise is an effective, weight-independent treatment for improving glycemia in individuals with diabetes.
- Additional research is necessary to refine exercise strategies and maximize health benefits, particularly in free-living conditions.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
233
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
233
Insulin: Dosing Regimen and Adverse Effects
141
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
141
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Carbohydrate Metabolism
10.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.8K
Hypoglycemia and Glucagon
150
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
150


